Evidence map›Paper›PMID 26665160›Full record

ArticleTobacco regulatory science2015

Providing a Science Base for the Evaluation of Tobacco Products.

Micah L Berman, Greg Connolly, K Michael Cummings, Mirjana V Djordjevic, Dorothy K Hatsukami, Jack E Henningfield, Matthew Myers, Richard J O'Connor, Mark Parascandola, Vaughan Rees and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Tobacco regulatory science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Pooled it
  4. Trial
  5. Risk Assessment Models for Heated Tobacco Products.Risk analysis : an official publication of the Society for Risk Analysis · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Consortium on Methods Evaluating Tobacco: Research Tools to Inform US Food and Drug Administration Regulation of Snus.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Micah L BermanThe Ohio State University College of Public Health, Columbus, OH.
Greg ConnollyNortheastern University Bouvé College of Health Sciences, Boston, MA.
K Michael CummingsMedical University of South Carolina Hollings Cancer Center, Charleston, SC.
Mirjana V DjordjevicNational Cancer Institute, Division of Cancer Control and Population Sciences, Bethesda, MD.
Dorothy K HatsukamiUniversity of Minnesota Tobacco Use Research Center, Minneapolis, MN.
Jack E HenningfieldThe Johns Hopkins University School of Medicine, Bethesda, MD.
Matthew MyersCampaign for Tobacco-Free Kids, Washington, DC.
Richard J O'ConnorRoswell Park Cancer Institute, Buffalo, NY.
Mark ParascandolaNational Cancer Institute, Division of Cancer Control and Population Sciences, Bethesda, MD.
Vaughan ReesHarvard School of Public Health, Boston, MA.
Jerry M RiceGeorgetown University Lombardi Comprehensive Cancer Center, Washington, DC.
Peter G ShieldsThe Ohio State University Comprehensive Cancer Center, Columbus, OH.
National Cancer Institute · USThe Ohio State University · USGeorgetown University · USHarvard University · USMedical University of South Carolina · USNortheastern University · USPartnership for Drug-Free Kids · USRoswell Park Comprehensive Cancer Center · US

Funding

Project 4: Comprehension of Health Risks in More and Less Arousing Affe p240-275P50CA180908 · NCI · OHIO STATE UNIVERSITY · PI SHIELDS, PETER G., WEWERS, MARY ELLEN · 2013 to 2017
$18.9M
NCI NIH HHS P50 CA180908
6 · The paper itself

Abstract

objectiveEvidence-based tobacco regulation requires a comprehensive scientific framework to guide the evaluation of new tobacco products and health-related claims made by product manufacturers.

methodsThe Tobacco Product Assessment Consortium (TobPRAC) employed an iterative process involving consortia investigators, consultants, a workshop of independent scientists and public health experts, and written reviews in order to develop a conceptual framework for evaluating tobacco products.

resultsThe consortium developed a four-phased framework for the scientific evaluation of tobacco products. The four phases addressed by the framework are: (1) pre-market evaluation, (2) pre-claims evaluation, (3) post-market activities, and (4) monitoring and re-evaluation. For each phase, the framework proposes the use of validated testing procedures that will evaluate potential harms at both the individual and population level.

conclusionsWhile the validation of methods for evaluating tobacco products is an ongoing and necessary process, the proposed framework need not wait for fully validated methods to be used in guiding tobacco product regulation today.

Indexed as

chemistryclinical trialsepidemiologyFDAhealth claimsModified Risk Tobacco Products (MRTPs)Potential Reduced Exposure Products (PREPs)surveillanceTobaccotoxicology

Identifiers

PMID26665160
PMCPMC4671507
OpenAlexW2412456781

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.